← Eichor
Study identifier: NCT05172089 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence

Condition: Chronic Wounds · Biofilm Infection · Trans-epidermal Water Loss (TEWL)  ·  Sponsor: University of Pittsburgh

PhaseN/A
Planned participants405
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This work is based on DFU patients, seeks to conduct a fully powered clinical study testing i) If DFU with a history of biofilm infection closes with deficient barrier function. ii) whether such functionally deficient wound closure, manifested as high TEWL, is associated with greater wound recurrence. The primary parent study will also address molecular mechanisms implicated in biofilm-induced loss of skin epithelial barrier integrity in DFU patients.

This description comes directly from the study's public registry record.

Talk to the study team

Piya Das Ghatak, PhD, MS  ·  4126240422  ·  piya.dasghatak@pitt.edu

Shomita S Steiner, PhD, MS  ·  463•236•8770  ·  SSTEINER@pitt.edu

Always discuss trial participation with your own doctor first.

Locations (2)

University of ArizonaTucson, Arizona, United StatesRecruiting
UPMC Wound Healing Services at UPMC PassavantCranberry Township, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05172089